Rytter L, Troelsen S, Beck-Nielsen H
Diabetes Care. 1985 May-Jun;8(3):230-4. doi: 10.2337/diacare.8.3.230.
The purpose of this study was to investigate if insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM) predispose to the development of acute myocardial infarction (AMI) and modify the prognosis. The study includes 832 AMI patients consecutively hospitalized over a 3-yr period. The prevalence of diabetes mellitus among the AMI patients was 9.7% and is significantly higher than in an age-matched population, where it is 6.1% (P less than 0.001). The prevalence of diabetes was higher for women than for men (14.9% versus 7.6%). The risk of AMI was found to be twice as high among IDDM than among nondiabetic patients (P less than 0.001). Men with NIDDM were not found to have a significantly higher risk of AMI (P greater than 0.1), but the risk of AMI in women with NIDDM was approximately doubled (P less than 0.01). During the first month following AMI the mortality rate for nondiabetic patients was 20.2% compared with 42.0% for diabetic patients (P less than 0.001). Insulin treatment in NIDDM was associated with a reduced mortality rate compared with treatment with oral agents (P less than 0.05). The mortality rate was significantly higher in patients with poor metabolic control compared with patients in good control, whether before AMI or at the time of hospitalization. Diabetic patients had a higher risk of developing cardiogenic shock and conduction disorders than nondiabetic patients. We conclude that diabetes mellitus disposes to AMI and that the mortality rate of AMI is significantly increased among diabetic patients. Poor metabolic regulation of the diabetes may aggravate the prognosis for AMI.
本研究的目的是调查胰岛素依赖型糖尿病(IDDM)和非胰岛素依赖型糖尿病(NIDDM)是否易患急性心肌梗死(AMI)并影响其预后。该研究纳入了在3年期间连续住院的832例AMI患者。AMI患者中糖尿病的患病率为9.7%,显著高于年龄匹配人群,后者为6.1%(P<0.001)。糖尿病在女性中的患病率高于男性(14.9%对7.6%)。发现IDDM患者发生AMI的风险是非糖尿病患者的两倍(P<0.001)。未发现NIDDM男性患者发生AMI的风险显著升高(P>0.1),但NIDDM女性患者发生AMI的风险约增加一倍(P<0.01)。在AMI后的第一个月,非糖尿病患者的死亡率为20.2%,而糖尿病患者为42.0%(P<0.001)。与口服药物治疗相比,NIDDM患者采用胰岛素治疗可降低死亡率(P<0.05)。无论在AMI前还是住院时,代谢控制差的患者死亡率显著高于控制良好的患者。糖尿病患者发生心源性休克和传导障碍的风险高于非糖尿病患者。我们得出结论,糖尿病易患AMI,糖尿病患者中AMI的死亡率显著增加。糖尿病代谢调节不良可能会加重AMI的预后。